Commerzbank Aktiengesellschaft FI Sells 32,236 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Commerzbank Aktiengesellschaft FI cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 37.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 54,687 shares of the healthcare conglomerate’s stock after selling 32,236 shares during the period. UnitedHealth Group makes up approximately 0.9% of Commerzbank Aktiengesellschaft FI’s portfolio, making the stock its 24th biggest position. Commerzbank Aktiengesellschaft FI’s holdings in UnitedHealth Group were worth $27,850,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. True Wealth Design LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $31,000. Delos Wealth Advisors LLC grew its position in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at $31,000. Signature Resources Capital Management LLC increased its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. Finally, Red Tortoise LLC boosted its stake in UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $1.87 during midday trading on Tuesday, reaching $580.65. The stock had a trading volume of 1,638,350 shares, compared to its average volume of 4,197,382. The company’s 50-day moving average is $532.75 and its 200 day moving average is $508.42. The company has a market capitalization of $536.18 billion, a price-to-earnings ratio of 35.49, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the company earned $6.14 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Barclays upped their price target on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. UBS Group increased their price target on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Wells Fargo & Company upped their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, August 13th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $614.17.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.